JPWO2022266324A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022266324A5 JPWO2022266324A5 JP2023577861A JP2023577861A JPWO2022266324A5 JP WO2022266324 A5 JPWO2022266324 A5 JP WO2022266324A5 JP 2023577861 A JP2023577861 A JP 2023577861A JP 2023577861 A JP2023577861 A JP 2023577861A JP WO2022266324 A5 JPWO2022266324 A5 JP WO2022266324A5
- Authority
- JP
- Japan
- Prior art keywords
- target gene
- item
- krab
- dnmt
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211791P | 2021-06-17 | 2021-06-17 | |
| US63/211,791 | 2021-06-17 | ||
| PCT/US2022/033797 WO2022266324A1 (en) | 2021-06-17 | 2022-06-16 | Systems and methods for regulating aberrant gene expressions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523394A JP2024523394A (ja) | 2024-06-28 |
| JP2024523394A5 JP2024523394A5 (https=) | 2025-06-13 |
| JPWO2022266324A5 true JPWO2022266324A5 (https=) | 2025-06-13 |
Family
ID=84525869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577861A Pending JP2024523394A (ja) | 2021-06-17 | 2022-06-16 | 異常な遺伝子発現を調節するためのシステムおよび方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240216482A1 (https=) |
| EP (1) | EP4355357A4 (https=) |
| JP (1) | JP2024523394A (https=) |
| KR (1) | KR20240032038A (https=) |
| CN (1) | CN117940150A (https=) |
| AU (1) | AU2022293494A1 (https=) |
| CA (1) | CA3221874A1 (https=) |
| GB (1) | GB2624791A (https=) |
| IL (1) | IL309174A (https=) |
| MX (1) | MX2023014750A (https=) |
| WO (1) | WO2022266324A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3192654A1 (en) | 2020-09-01 | 2022-03-10 | The Board Of Trustees Of The Leland Stanford Junior Unversity | Synthetic miniature crispr-cas (casmini) system for eukaryotic genome engineering |
| WO2023168242A1 (en) | 2022-03-01 | 2023-09-07 | Epicrispr Biotechnologies, Inc. | Engineered nucleases, compositions, and methods of use thereof |
| AU2024235956A1 (en) * | 2023-03-16 | 2025-09-18 | Epicrispr Biotechnologies, Inc. | Systems and methods for regulating aberrant gene expressions |
| CN119955797B (zh) * | 2025-01-13 | 2026-01-23 | 江南大学 | Kif5b基因在调控成肌细胞生理活性中的功能和应用 |
| CN119954926B (zh) * | 2025-03-11 | 2025-10-28 | 华南农业大学 | Klf5转录因子在调控猪骨骼肌发育中的应用及方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190127713A1 (en) * | 2016-04-13 | 2019-05-02 | Duke University | Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use |
| CA3074723A1 (en) * | 2016-09-23 | 2018-03-29 | University Of Massachusetts | Silencing of dux4 by recombinant gene editing complexes |
| AU2019419494B2 (en) * | 2018-12-31 | 2026-03-26 | Research Institute At Nationwide Children's Hospital | DUX4 RNA silencing using RNA targeting CRISPR-Cas13b |
| WO2022133062A1 (en) * | 2020-12-16 | 2022-06-23 | Epicrispr Biotechnologies, Inc. | Systems and methods for engineering characteristics of a cell |
-
2022
- 2022-06-16 GB GB2319324.6A patent/GB2624791A/en active Pending
- 2022-06-16 CA CA3221874A patent/CA3221874A1/en active Pending
- 2022-06-16 JP JP2023577861A patent/JP2024523394A/ja active Pending
- 2022-06-16 AU AU2022293494A patent/AU2022293494A1/en active Pending
- 2022-06-16 KR KR1020247001784A patent/KR20240032038A/ko active Pending
- 2022-06-16 CN CN202280056393.0A patent/CN117940150A/zh active Pending
- 2022-06-16 IL IL309174A patent/IL309174A/en unknown
- 2022-06-16 WO PCT/US2022/033797 patent/WO2022266324A1/en not_active Ceased
- 2022-06-16 MX MX2023014750A patent/MX2023014750A/es unknown
- 2022-06-16 EP EP22825819.0A patent/EP4355357A4/en active Pending
-
2023
- 2023-12-15 US US18/542,396 patent/US20240216482A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2624791A (en) | Systems and methods for regulating aberrant gene expressions | |
| AU2021230545A1 (en) | Improved methods and compositions for modulating a genome | |
| US20210047375A1 (en) | Lentiviral-based vectors and related systems and methods for eukaryotic gene editing | |
| JP2023518395A (ja) | 指向性ゲノム編集のための方法及び組成物 | |
| JP2021526858A5 (https=) | ||
| CA3097857A1 (en) | Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna | |
| JP2021511047A5 (https=) | ||
| JP2017506885A (ja) | アデノ随伴ウイルスベクターの高力価産生 | |
| US20240132855A1 (en) | Compositions and methods for epigenetic regulation of hbv gene expression | |
| CA3025523A1 (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| JP2024099770A5 (https=) | ||
| JP2024107295A5 (https=) | ||
| Suzuki et al. | Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position | |
| WO2024131940A1 (zh) | 融合物及其用途 | |
| RU2022105597A (ru) | Искусственно созданная система управления функцией шк | |
| JPWO2022266324A5 (https=) | ||
| JPWO2022256440A5 (https=) | ||
| JPWO2019236982A5 (https=) | ||
| JPWO2020082047A5 (https=) | ||
| JPWO2020210507A5 (https=) | ||
| WO2023214512A1 (ja) | 人工ｒｎａ分子 | |
| JPWO2022081890A5 (https=) | ||
| US20230220361A1 (en) | Crispr-cas9 mediated disruption of alcam gene inhibits adhesion and trans-endothelial migration of myeloid cells | |
| WO2023147558A2 (en) | Crispr methods for correcting bag3 gene mutations in vivo | |
| JPWO2020176776A5 (https=) |